username: password:     Join free | Forgot password
Add to favorites    中文
home > news and events
BIO Statement regarding the Innovation Act, H.R. 3309

Clicks:489 Date:12/05/13

WASHINGTON--()--The Biotechnology Industry Organization (BIO) today issued the following statement regarding the Innovation Act (H.R. 3309), as reported by the House Judiciary Committee:

鈥淭he Innovation Act was introduced with the goal of furthering patent system reform, particularly with respect to patent-related litigation. We support increased transparency and oppose abusive litigation tactics.鈥

"The Innovation Act was introduced with the goal of furthering patent system reform, particularly with respect to patent-related litigation. We support increased transparency and oppose abusive litigation tactics.

鈥淯nfortunately, provisions in the Act remain overly broad in important respects and, if ultimately enacted, would continue to result in too many unintended and unknowable consequences for innovators who rely on the patent system to fund and protect their inventions.

鈥淧rovisions in the legislation would erect unreasonable barriers to access justice for innovators, especially small start-ups that must be able to defend their businesses against patent infringement in a timely and cost-effective manner, and without needless and numerous procedural hurdles or other obstacles.

"While we have been working to improve the legislation and appreciate some of the modifications that have been made by the bill鈥檚 sponsors, these changes have not been sufficient to adequately address our concerns, and therefore BIO cannot support the legislation in its current form.鈥

To learn more about BIO and the biotech industry, please visit http://www.bio.org.

About BIO
BIO is the world鈥檚 largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world鈥檚 largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO鈥檚 blog chronicling 鈥渋nnovations transforming our world鈥 and the BIO Newsletter is the organization鈥檚 bi-weekly email newsletter.鈥 Subscribe to the BIO Newsletter.

Upcoming BIO Events

Pacific Rim Summit on Industrial Biotechnology & Bioenergy
December 8-11, 2013
San Diego, CA

BIO CEO & Investor Conference
February 10鈥11, 2014
New York, NY

BIO Asia International Conference
April 8-9, 2014
Tokyo, Japan

World Congress on Industrial Biotechnology
May 12-15, 2014
Philadelphia, PA

BIO International Convention
June 23-26, 2014
San Diego, CA

Livestock Biotech Summit
September 16-18, 2014
Sioux Falls, SD

Contacts
Biotechnology Industry Organization
Tracy Cooley, 202-312-9274
Web: www.bio.org
Blog: www.biotech-now.org
Twitter: @IAmBiotech

Recent Stories

BIO Announces Patrick Plues as the New Senior Director of State Government Relations WASHINGTON--(BUSINESS WIRE)--BIO announced today that Patrick Plues has been hired to serve as Senior Director of State Government Relations. more » San Diego Interim Mayor Todd Gloria to Discuss Economic Development Initiatives that Support Growth of Local Biotech Industry --(BUSINESS WIRE)--San Diego Interim Mayor Gloria will discuss economic and jobs data demonstrating value of the area鈥檚 biotech industry, while previewing the BIO International Convention.more » BIO Praises Senate for Passing Single, Uniform and National Traceability System to Safeguard U.S. Pharmaceutical Supply Chain WASHINGTON--(BUSINESS WIRE)--Today, the Biotechnology Industry Organization (BIO) applauds the Senate for approving H.R. 3204, the Drug Quality and Security Act, which will create a single, uniform... more »

Related News>> more
advertisement

Copyright(C) 2006-2014 bio-equip    E-mail:web@bio-equip.cn   娌狪CP澶06040519鍙